The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
- PMID: 15668716
- PMCID: PMC2362088
- DOI: 10.1038/sj.bjc.6602307
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
Abstract
The British mesothelioma register contains all deaths from 1968 to 2001 where mesothelioma was mentioned on the death certificate. These data were used to predict the future burden of mesothelioma mortality in Great Britain. Poisson regression analysis was used to model male mesothelioma deaths from 1968 to 2001 as a function of the rise and fall of asbestos exposure during the 20th century, and hence to predict numbers of male deaths in the years 2002-2050. The annual number of mesothelioma deaths in Great Britain has risen increasingly rapidly from 153 deaths in 1968 to 1848 in 2001 and, using our preferred model, is predicted to peak at around 1950 to 2450 deaths per year between 2011 and 2015. Following this peak, the number of deaths is expected to decline rapidly. The eventual death rate will depend on the background level and any residual asbestos exposure. Between 1968 and 2050, there will have been approximately 90,000 deaths from mesothelioma in Great Britain, 65,000 of which will occur after 2001.
Figures





Similar articles
-
Simple benchmark for mesothelioma projection for Great Britain.Occup Environ Med. 2016 Aug;73(8):561-3. doi: 10.1136/oemed-2015-103303. Epub 2016 May 31. Occup Environ Med. 2016. PMID: 27245376
-
Mortality from asbestosis and mesothelioma in Britain by birth cohort.Occup Med (Lond). 2012 Oct;62(7):549-52. doi: 10.1093/occmed/kqs119. Epub 2012 Jul 25. Occup Med (Lond). 2012. PMID: 23034792 Free PMC article.
-
Continuing increase in mesothelioma mortality in Britain.Lancet. 1995 Mar 4;345(8949):535-9. doi: 10.1016/s0140-6736(95)90462-x. Lancet. 1995. PMID: 7776771
-
Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma.Eur J Cancer Prev. 2012 May;21(3):227-30. doi: 10.1097/CEJ.0b013e32834dbc56. Eur J Cancer Prev. 2012. PMID: 22314851 Review.
-
Risk analysis for mortality from respiratory tumors in a cohort of refractory ceramic fiber workers.Regul Toxicol Pharmacol. 2002 Feb;35(1):95-104. doi: 10.1006/rtph.2001.1513. Regul Toxicol Pharmacol. 2002. PMID: 11846639 Review.
Cited by
-
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections.Occup Environ Med. 2016 Sep;73(9):607-13. doi: 10.1136/oemed-2016-103652. Epub 2016 Jun 16. Occup Environ Med. 2016. PMID: 27312399 Free PMC article.
-
BTS statement on malignant mesothelioma in the UK, 2007.Thorax. 2007 Nov;62 Suppl 2(Suppl 2):ii1-ii19. doi: 10.1136/thx.2007.087619. Thorax. 2007. PMID: 17965072 Free PMC article. No abstract available.
-
The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.Br J Cancer. 2010 Feb 2;102(3):553-60. doi: 10.1038/sj.bjc.6605501. Epub 2010 Jan 5. Br J Cancer. 2010. PMID: 20051956 Free PMC article.
-
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.Cancer Immunol Immunother. 2010 Oct;59(10):1543-9. doi: 10.1007/s00262-010-0881-6. Epub 2010 Jun 22. Cancer Immunol Immunother. 2010. PMID: 20567822 Free PMC article.
-
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth.Oncoimmunology. 2018 Nov 2;8(2):e1537427. doi: 10.1080/2162402X.2018.1537427. eCollection 2019. Oncoimmunology. 2018. PMID: 30713792 Free PMC article.
References
-
- Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6: 162–166 - PubMed
-
- Doll R, Peto J (1985) Effects on Health of Exposure to Asbestos. London: HMSO
-
- Health Effects Institute (1991) Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge. Cambridge, MA: Health Effects Institute – Asbestos Research
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical